Optimization of Medication Regimens in Patients with Type 2 Diabetes and Clinical Atherosclerotic Cardiovascular Disease

The American Diabetes Association recommends that patients with type II diabetes and atherosclerotic cardiovascular disease be prescribed an SGLT-2 inhibitor or GLP-1 agonist for cardioprotective benefit. This project assessed the use of these medications in this patient population in a rural clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Prudencio, Jarred, Cajudoy, Paige, Waddell, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628975/
https://www.ncbi.nlm.nih.gov/pubmed/34842818
http://dx.doi.org/10.3390/pharmacy9040186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628975/
https://www.ncbi.nlm.nih.gov/pubmed/34842818
http://dx.doi.org/10.3390/pharmacy9040186

Ejemplares similares